Search
Abcellera Biologics Inc
ABCLAdd to Watchlist
7.600USD
-0.250-3.18%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.31BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2024Q2
FY2023Q2
By BusinessUSD
Name
Revenue
Proportion
Licensing revenue
46.92M
62.45%
Research fees
27.21M
36.22%
Milestone payments
1.00M
1.33%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Licensing revenue
46.92M
62.45%
Research fees
27.21M
36.22%
Milestone payments
1.00M
1.33%